{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "79802-200",
      "generic_name": "belumosudil",
      "labeler_name": "Kadmon Pharmaceuticals, LLC",
      "brand_name": "Rezurock",
      "active_ingredients": [
        {
          "name": "BELUMOSUDIL",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "79802-200-30",
          "description": "1 BOTTLE in 1 CARTON (79802-200-30)  / 30 TABLET in 1 BOTTLE",
          "marketing_start_date": "20210716",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Kadmon Pharmaceuticals, LLC"
        ],
        "rxcui": [
          "2564031",
          "2564037"
        ],
        "spl_set_id": [
          "102e4ef4-7f84-4e34-8df1-479c24d1575d"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "834YJF89WO"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "65249371-3fc5-4a85-a999-9ed367b8dd73",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210716",
      "product_id": "79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73",
      "application_number": "NDA214783",
      "brand_name_base": "Rezurock"
    }
  ]
}